Barclays »

Travere Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Travere Therapeutics shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2025-12-31 $221k 155k 1.43
2025-06-30 $195k 204k 0.96
2025-03-31 $45k 45k 1.00